Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.1 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |